The medical management of abnormal uterine bleeding in reproductive-aged women

LD Bradley, NA Gueye - American journal of Obstetrics and Gynecology, 2016 - Elsevier
In the treatment of women with abnormal uterine bleeding, once a thorough history, physical
examination, and indicated imaging studies are performed and all significant structural …

A systematic review evaluating health‐related quality of life, work impairment, and health‐care costs and utilization in abnormal uterine bleeding

Z Liu, QV Doan, P Blumenthal, RW Dubois - Value in health, 2007 - Wiley Online Library
Objectives: Abnormal uterine bleeding (AUB) impacts women's health‐related quality of life
(HRQoL) and puts a heavy economic burden on society. To date, this burden has not been …

[HTML][HTML] US medical eligibility criteria for contraceptive use, 2016

KM Curtis - MMWR. Recommendations and Reports, 2016 - cdc.gov
Summary The 2016 US Medical Eligibility Criteria for Contraceptive Use (US MEC)
comprises recommendations for the use of specific contraceptive methods by women and …

[图书][B] Medical eligibility criteria for contraceptive use

World Health Organization. Reproductive Health - 2010 - books.google.com
Medical Eligibility Criteria for Contraceptive Use reviews the medical eligibility criteria for
use of contraception, offering guidance on the safety and use of different methods for women …

[HTML][HTML] US medical eligibility criteria for contraceptive use, 2024

AT Nguyen - MMWR. Recommendations and Reports, 2024 - cdc.gov
Summary The 2024 US Medical Eligibility Criteria for Contraceptive Use (US MEC)
comprises recommendations for the use of specific contraceptive methods by persons who …

Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility

A Manca, N Hawkins, MJ Sculpher - Health economics, 2005 - Wiley Online Library
In trial‐based cost‐effectiveness analysis baseline mean utility values are invariably
imbalanced between treatment arms. A patient's baseline utility is likely to be highly …

Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial

AM de Bruijn, WM Ankum, JA Reekers, E Birnie… - American journal of …, 2016 - Elsevier
Background Since 1995 uterine artery embolization has been described as an alternative for
hysterectomy in patients with symptomatic fibroids. Many studies including several …

Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland

T Soini, R Hurskainen, S Grénman… - Obstetrics & …, 2014 - journals.lww.com
OBJECTIVE: To examine the association between premenopausal use of the levonorgestrel-
releasing intrauterine system and cancer incidence in Finland with a special focus on …

Surgery versus medical therapy for heavy menstrual bleeding

J Marjoribanks, A Lethaby… - Cochrane Database of …, 2016 - cochranelibrary.com
Background Heavy menstrual bleeding significantly impairs the quality of life of many
otherwise healthy women. Perception of heavy menstrual bleeding is subjective and …

Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up

R Hurskainen, J Teperi, P Rissanen, AM Aalto… - Jama, 2004 - jamanetwork.com
ContextBecause menorrhagia is often a reason for seeking medical attention, it is important
to consider outcomes and costs associated with alternative treatment modalities. Both the …